checkAd

     174  0 Kommentare Intellia Therapeutics Announces Pricing of Public Offering of Common Stock - Seite 3

    Intellia Contacts:

    Investors:
     Lina Li
    Associate Director
    Investor Relations
    +1 857-706-1612
    lina.li@intelliatx.com

    Lesen Sie auch

    Media:
     Jennifer Mound Smoter
    Senior Vice President
    External Affairs & Communications
    +1 857-706-1071
    jenn.smoter@intelliatx.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Intellia Therapeutics Announces Pricing of Public Offering of Common Stock - Seite 3 CAMBRIDGE, Mass., June 02, 2020 (GLOBE NEWSWIRE) - Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, announced today the …